Deborah Unger
writer, editor, now working with Lost Women of Science Initiative; unsuccessful Lib Dem candidate, hopeful gardener, views my own
Articles
Remembering Margarethe Hilferding, the First Woman Admitted to Freud’s Vienna Psychoanalytic Society
Jan 23, 2025 |
scientificamerican.com | Marcy Thompson |Katie Hafner |Deborah Unger
In honor of International Holocaust Remembrance Day next week, Lost Women of Science is telling the story of Margarethe Hilferding, a pioneering psychoanalyst and physician from Vienna who was murdered in a Nazi concentration camp in 1942. She was the first woman to earn a medical degree at the University of Vienna and the first woman to join Sigmund Freud’s Vienna Psychoanalytic Society.
-
Oct 10, 2024 |
scientificamerican.com | Katie Hafner |Elah Feder |Deborah Unger
It’s September 2024, and a group of American thalidomide survivors and their family members arrive in Washington, D.C., to lobby the government for support. More than 60 years have gone by since Food and Drug Administration medical examiner Frances Oldham Kelsey first stalled the new drug application for thalidomide from the pharmaceutical company Richardson-Merrell.
-
Oct 3, 2024 |
scientificamerican.com | Katie Hafner |Elah Feder |Deborah Unger
It’s the summer of 1962, and the drug thalidomide has been off the market in Europe for months after it was determined to be unsafe to use during pregnancy. But in the U.S., people are only just beginning to find out about the scandal. The Washington Post breaks the story and puts a picture of Food and Drug Administration medical examiner Frances Oldham Kelsey, who refused to approve the medication, on the front page. She’s the hero who saved American lives. President John F.
-
Sep 26, 2024 |
scientificamerican.com | Katie Hafner |Elah Feder |Deborah Unger
It’s the early 1960s, and Widukind Lenz, a German pediatrician, is going door to door in his efforts to find out what is causing an epidemic of babies born with shortened limbs and other serious medical conditions. In the U.S. the drug company Richardson-Merrell is battling with Frances Oldham Kelsey at the Food and Drug Administration about the pending approval of thalidomide. She’s asking for data that show it’s safe to use during pregnancy (spoiler alert: it’s not).
-
Mar 16, 2023 |
strategy-business.com | Deborah Unger
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 781
- Tweets
- 5K
- DMs Open
- No
Conclave was a recent primer on what to expect behind the Vatican’s closed doors. My Charlie and Lucinda mystery tells a different, far-fetched story of power and papal intrigue. It starts with the murder of a nun. https://t.co/LWvmhNHRfb
Cyber attacks don’t ride in on horseback—they slip in through weak passwords, phishing emails, and unpatched systems. Join the Pause to protect yourself, your community, and our country at https://t.co/OUF9d7DI99 #Take9 @pausetake9 @craignewmark This is really, really important
https://t.co/i3Io49wIPm
